Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ctDNA in Resectable Hepatic Metastatic Uveal Melanoma
NCT02849145Completed
- Sponsor
- Institut Curie
- Start
- Sep 2014
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut Curie. Primary endpoint: Correlation between the circulating tumor DNA rate before/after surgery and the rate of effective complete resection. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02849145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849145.